Document Detail


Inflammatory bowel disease: perspectives from cingulate cortex in the first brain.
MedLine Citation:
PMID:  23336589     Owner:  NLM     Status:  In-Data-Review    
Abstract/OtherAbstract:
The article by Agostini et al. (2013) in this issue of Neurogastroenterology and Motility evaluated patients with Crohn's disease (CD) for volumetric changes throughout the brain. They observed decreased gray matter volumes in dorsolateral prefrontal cortex and anterior midcingulate cortex (aMCC) and disease duration was negatively correlated with volumes in subgenual anterior cingulate (sACC), posterior MCC (pMCC), ventral posterior cingulate (vPCC), and parahippocampal cortices. As all patients were in remission and suffered from ongoing abdominal pain, this study provides a critical link between forebrain changes and abdominal pain experience independent of active disease and drug treatment. The aMCC has a role in feedback-mediated decision making and there are specific cognitive tasks that differentiate aMCC and pMCC that can be used to evaluate defects in CD. The sACC is an important area as it has impaired functions in major depression. As depressive symptoms are a feature in a subset of patients with active inflammatory diseases including IBD, treatment targeting this subregion should prove efficacious. Finally, vPCC has a role in ongoing self-monitoring of the personal relevance of sensory stimuli including visceral signals via sACC. This pathway may be interrupted by vPCC atrophy in CD. Cingulate atrophy in CD leads to targeting chronic pain and psychiatric symptoms via cingulate-mediated therapies. These include psychotherapy, guided imagery and relaxation training, analgesic dosages of morphine or antidepressants, and hypnosis. Thus, a new generation of novel treatments may emerge from drug and non-traditional therapies for CD in this formative area of research.
Authors:
B A Vogt
Related Documents :
10389609 - Clinical rating of compliance in chronic hemodialysis patients.
1745939 - Outpatient compliance with theophylline and phenytoin therapy.
23842019 - Unmet needs in the assessment and management of bipolar i depression.
19362029 - A systematic review of continuous positive airway pressure for obstructive sleep apnoea...
23133339 - Transcranial direct current stimulation in tinnitus patients: a systemic review and met...
21627519 - Effect of topical vapocoolant spray on response to arthrocentesis and intravenous cathe...
17238129 - A case study comparing a randomized withdrawal trial and a double-blind long-term trial...
22177379 - Clinical relevance of treatments for acute bipolar disorder: balancing therapeutic and ...
10908099 - Psychiatric inferences from data on psychologic/psychiatric symptoms in multiple chemic...
Publication Detail:
Type:  Journal Article    
Journal Detail:
Title:  Neurogastroenterology and motility : the official journal of the European Gastrointestinal Motility Society     Volume:  25     ISSN:  1365-2982     ISO Abbreviation:  Neurogastroenterol. Motil.     Publication Date:  2013 Feb 
Date Detail:
Created Date:  2013-01-22     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  9432572     Medline TA:  Neurogastroenterol Motil     Country:  England    
Other Details:
Languages:  eng     Pagination:  93-8     Citation Subset:  IM    
Copyright Information:
© 2013 Blackwell Publishing Ltd.
Affiliation:
Cingulum Neurosciences Institute, Manlius, NY, USA Boston University School of Medicine, Boston, MA, USA Institute of Neurosciences and Medicine (INM-1) Research Centre Jülich, Jülich, Germany.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Differences in acute metabolism of fructose between hemodialysis patients and healthy subjects.
Next Document:  Evaluation of esophageal motor function in clinical practice.